The most important tool to obtain insight into the function of genes is the
use of mutant model organisms. Homologous recombination in embryonic stem
cells allows the systematic production of mouse mutants for any gene that h
as been cloned. Gene trap strategies have been designed to interrupt even u
nknown genes which are tagged by the inserted vector and can be characteriz
ed structurally and functionally. Complementary to such 'gene-driven' appro
aches, 'phenotype-driven' approaches are necessary to identify new genes or
gene products through a search for mutants with specific defects, e.g. in
immune function and resistance to infectious diseases. Mutagenesis using th
e alkylating agent N-ethyI-N-nitrosourea (ENU) is a powerful approach for t
he production of mouse mutants (mainly point mutations). ENU mutagenizes -
among other cells - premeiotic spermatogonia of F0 males which can be bred
to produce a large number of G1 offspring or G3 pedigrees, respectively. It
has been demonstrated for certain loci that the Frequency of mutant recove
ry is about 1/1000 (recessive mutation) or 1/5000 (dominant mutation) far a
specific locus that can be scored phenotypically, although strain as well
as dosage and treatment regime do influence the mutagenesis rate. The mutan
ts produced will be mainly hypomorphic, although gain-of-function and compl
ete loss-of-function mutants can also be expected. These mutants are import
ant tools for the identification of candidate genes for animal health, offe
ring new strategies for the prevention, diagnosis, and therapy of diseases.